Sherer Y - Search Results

1

Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis.

Sherer Y, Shoenfeld Y. Sherer Y, et al. Curr Atheroscler Rep. 2001 Jul;3(4):328-33. doi: 10.1007/s11883-001-0027-6. Curr Atheroscler Rep. 2001. PMID: 11389799 Review.

2

Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins.

Krause I, Blank M, Sherer Y, Gilburd B, Kvapil F, Shoenfeld Y. Krause I, et al. Among authors: sherer y. Eur J Immunol. 2002 Dec;32(12):3414-24. doi: 10.1002/1521-4141(200212)32:12<3414::AID-IMMU3414>3.0.CO;2-F. Eur J Immunol. 2002. PMID: 12432572 Free article.

3

Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis?

Sherer Y, Shoenfeld Y. Sherer Y, et al. Immunobiology. 2003;207(1):13-6. doi: 10.1078/0171-2985-00212. Immunobiology. 2003. PMID: 12638897 Review.

4

Immunomodulation for treatment and prevention of atherosclerosis.

Sherer Y, Shoenfeld Y. Sherer Y, et al. Autoimmun Rev. 2002 Feb;1(1-2):21-7. doi: 10.1016/s1568-9972(01)00003-9. Autoimmun Rev. 2002. PMID: 12849054 Review.

5

Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.

Sherer Y, Gerli R, Vaudo G, Schillaci G, Gilburd B, Giordano A, Bocci EB, Allegrucci R, Marchesi S, Mannarino E, Shoenfeld Y. Sherer Y, et al. Ann N Y Acad Sci. 2005 Jun;1051:299-303. doi: 10.1196/annals.1361.071. Ann N Y Acad Sci. 2005. PMID: 16126971

6

[Accelerated atherosclerosis in rheumatoid arthritis].

Shepshelovich D, Sherer Y, Shoenfeld Y. Shepshelovich D, et al. Among authors: sherer y. Harefuah. 2005 Aug;144(8):561-3, 598. Harefuah. 2005. PMID: 16146154 Review. Hebrew.

7

[Dermatological manifestations in the antiphospholipid syndrome].

Twig G, Sherer Y, Shoenfeld Y. Twig G, et al. Among authors: sherer y. Harefuah. 2005 Sep;144(9):639-41, 675. Harefuah. 2005. PMID: 16218536 Review. Hebrew.

8

The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity.

Harel M, Aron-Maor A, Sherer Y, Blank M, Shoenfeld Y. Harel M, et al. Among authors: sherer y. Immunobiology. 2005;210(10):743-7. doi: 10.1016/j.imbio.2005.10.004. Epub 2005 Oct 21. Immunobiology. 2005. PMID: 16325492 Review.

9

Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.

Shovman O, Gilburd B, Zandman-Goddard G, Sherer Y, Shoenfeld Y. Shovman O, et al. Among authors: sherer y. Curr Rheumatol Rep. 2006 Aug;8(4):292-8. doi: 10.1007/s11926-006-0012-8. Curr Rheumatol Rep. 2006. PMID: 16839508 Review.

10

Mechanisms of disease: atherosclerosis in autoimmune diseases.

Sherer Y, Shoenfeld Y. Sherer Y, et al. Nat Clin Pract Rheumatol. 2006 Feb;2(2):99-106. doi: 10.1038/ncprheum0092. Nat Clin Pract Rheumatol. 2006. PMID: 16932663 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters